International Pulmonary Fibrosis (IPF) Summit

For a decade, the IPF Summit has been the go-to intimate discussion-based forum uniting stakeholders across the pulmonary fibrosis landscape, and this year, the conversation has never been more critical.
Offering a uniquely integrated view of challenges and opportunities defining the next decade of IPF drug development, from novel biology and biomarker-driven strategies to next-generation trial design and combination approaches, this is where leaders come to align on what success now looks like.